Epidarex Capital
Overview
Epidarex Capital is a transatlantic venture firm that invests in early-stage, high-growth life science companies in under-ventured markets. Epidarex focuses on providing risk capital and expertise to create, support and build young companies, including spinouts, from leading research institutions in both established and emerging life science hubs. The fund's international management team has a track record of successfully partnering with top scientists and entrepreneurs to develop highly innovative products for the global healthcare market.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rezera Inc. | Sep 2022 | Series C | Co-investor |
| Eternygen GmbH | Oct 2020 | Series A Extension | Co-investor |
| Nyra Medical | Nov 2022 | Series A | Co-investor |
| Enterprise Therapeutics | Jan 2024 | Series B Extension | Co-investor |
| Curve Therapeutics | Feb 2024 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Kyparissia Sirinakis
Co-Founder Managing Partner
Sinclair Dunlop
Managing Partner
Henning Steinhagen
Venture Partner
Lori Gough
Partner
Peter Finan
Partner
Matthew Miessau
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Epidarex Capital based?
Epidarex Capital is headquartered in Bethesda, Maryland, United States.
When was Epidarex Capital founded?
Epidarex Capital was founded in 2010.
How many portfolio companies does Epidarex Capital have?
Epidarex Capital has 25 portfolio companies in Caplight's dataset.
What are some companies in Epidarex Capital's portfolio?
Portfolio companies visible on Caplight include Rezera Inc., Eternygen GmbH, Nyra Medical, Enterprise Therapeutics, Curve Therapeutics.
What was Epidarex Capital's most recent investment shown here?
Epidarex Capital's most recent investment in this portfolio sample was in Curve Therapeutics in 2024.
What sectors does Epidarex Capital focus on?
Epidarex Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Epidarex Capital focus on?
Epidarex Capital typically invests at the Early stage.
What is Epidarex Capital's AUM?
Epidarex Capital's assets under management are estimated between $100.0M and $250.0M.